Latest Breaking News On - Stefanj scherer - Page 1 : comparemela.com

Boehringer double dips at 3T, inking second T-cell anticancer deal to swell potential payday to $538.5M

Boehringer double dips at 3T, inking second T-cell anticancer deal to swell potential payday to $538.5M
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

Germany
German
Bryan-irving
Stefanj-scherer
Lamine-mbow
Boehringer-ingelheim
Estelle-marrer-berger

Boehringer Ingelheim and 3T Biosciences enter into a second partnership to develop next-generation cancer immunotherapies

Boehringer Ingelheim and 3T Biosciences enter into a second partnership to develop next-generation cancer immunotherapies
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Germany
Prnewswire-boehringer-ingelheim
Lamine-mbow
Engagers-tces
Stefanj-scherer
Parker-institute-for-cancer-immunotherapy
Boehringer-ingelheim
Animal-health
T-cell-engagers
T-cell-receptor-antigen
Cross-reactivity-engine
Global-head

3T Biosciences Expands Leadership Team With Bryan Irving, Ph.D., as Chief Scientific Officer to Progress Tumor-specific Therapies to Clinic

3T Biosciences Expands Leadership Team With Bryan Irving, Ph.D., as Chief Scientific Officer to Progress Tumor-specific Therapies to Clinic
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San-francisco
California
United-states
South-san-francisco
France
Louis-pasteur
Bryan-irving
Stefanj-scherer
Amunix-pharmaceuticals
Parker-institute-for-cancer-immunotherapy
University-of-california
Nature-communications

Boehringer Ingelheim and 3T Biosciences Join Forces to Develop Next-Generation Cancer Immunotherapies

Boehringer Ingelheim and 3T Biosciences Join Forces to Develop Next-Generation Cancer Immunotherapies
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Germany
Prnewswire-boehringer-ingelheim
Lamine-mbow
Boehringer-ingelheim
Boehringer-ingelheimboehringer-ingelheim
Stefanj-scherer
Animal-health
Parker-institute-for-cancer-immunotherapy
T-cell-receptor-antigen
Cross-reactivity-engine
Global-head
Cancer-immunology

3T Biosciences Announces Appointment of John Leonard, M.D. to its Board of Directors

3T Biosciences Announces Appointment of John Leonard, M.D. to its Board of Directors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Stefanj-scherer
John-leonard
National-institutes-of-health
Johns-hopkins-university-school-of-medicine
Parker-institute-for-cancer-immunotherapy
Stanford-university
Intellia-therapeutics
Johns-hopkins-university-school
National-institutes
South-san-francisco
Westlake-village-biopartners
Lightspeed-venture-partners